86 related articles for article (PubMed ID: 23811455)
1. The effects of taurochenodeoxycholic acid in preventing pulmonary fibrosis in mice.
Zhou C; Shi Y; Li J; Zhang W; Wang Y; Liu Y; Liu J
Pak J Pharm Sci; 2013 Jul; 26(4):761-5. PubMed ID: 23811455
[TBL] [Abstract][Full Text] [Related]
2. Effects of taurochenodeoxycholic acid on Ca
Lei Z; Xudong W; Wei M
Pharmazie; 2016 Jul; 71(7):390-393. PubMed ID: 29441914
[TBL] [Abstract][Full Text] [Related]
3. Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5.
Qi Y; Shi L; Duan G; Ma Y; Li P
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885648
[TBL] [Abstract][Full Text] [Related]
4. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
[TBL] [Abstract][Full Text] [Related]
5. The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice.
Tanaka Y; Ishitsuka Y; Hayasaka M; Yamada Y; Miyata K; Endo M; Kondo Y; Moriuchi H; Irikura M; Tanaka K; Mizushima T; Oike Y; Irie T
Pharmacol Res; 2015 Sep; 99():52-62. PubMed ID: 26005208
[TBL] [Abstract][Full Text] [Related]
6. Low dose pirfenidone suppresses transforming growth factor beta-1 and tissue inhibitor of metalloproteinase-1, and protects rats from lung fibrosis induced by bleomycina.
Tian XL; Yao W; Guo ZJ; Gu L; Zhu YJ
Chin Med Sci J; 2006 Sep; 21(3):145-51. PubMed ID: 17086734
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
8. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
9. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
[TBL] [Abstract][Full Text] [Related]
10. [Anti-type IV collagenase single-chain antibody ameliorates bleomycin-induced experimental pulmonary fibrosis in mice].
Lai RY; Miao QF; Li Y; Zhen YS
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1411-5. PubMed ID: 19671337
[TBL] [Abstract][Full Text] [Related]
11. Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodelling.
Gao J; Feng LJ; Huang Y; Li P; Xu DJ; Li J; Wu Q
J Pharm Pharmacol; 2012 Jun; 64(6):811-20. PubMed ID: 22571259
[TBL] [Abstract][Full Text] [Related]
12. Unbalanced MMP/TIMP-1 expression during the development of experimental pulmonary fibrosis with acute paraquat poisoning.
Wang BL; Tu YY; Fu JF; Zhong YX; Fu GQ; Tian XX; Wang LH; Gong L; Ren QY
Mol Med Rep; 2011; 4(2):243-8. PubMed ID: 21468558
[TBL] [Abstract][Full Text] [Related]
13. Effect of antisense TIMP-1 cDNA on the expression of TIMP-1 and MMP-2 in lung tissue with pulmonary fibrosis induced by bleomycin.
Tang H; Mao J; Gao L; Liu J; Wu T
Mol Med Rep; 2013 Jan; 7(1):149-53. PubMed ID: 23124168
[TBL] [Abstract][Full Text] [Related]
14. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis.
Madtes DK; Elston AL; Kaback LA; Clark JG
Am J Respir Cell Mol Biol; 2001 May; 24(5):599-607. PubMed ID: 11350830
[TBL] [Abstract][Full Text] [Related]
15. Antifibrosis effects of triterpene acids of Eriobotrya japonica (Thunb.) Lindl. leaf in a rat model of bleomycin-induced pulmonary fibrosis.
Yang Y; Huang Y; Huang C; Lv X; Liu L; Wang Y; Li J
J Pharm Pharmacol; 2012 Dec; 64(12):1751-60. PubMed ID: 23146038
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin attenuates bleomycin-induced pulmonary fibrosis in rats and the expression of metalloproteinase-9 and tissue inhibitors of metalloproteinase-1 in lung tissue.
Jin X; Dai H; Ding K; Xu X; Pang B; Wang C
Chin Med J (Engl); 2014; 127(7):1304-9. PubMed ID: 24709185
[TBL] [Abstract][Full Text] [Related]
17. [mRNA expression of matrix metalloproteinase-2 and membrane type matrix metalloproteinase in pulmonary fibroblasts and macrophages of rat pulmonary fibrosis model].
Lu S; Zhang N; Zhang X
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Sep; 24(9):527-30. PubMed ID: 11758165
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome investigation of anti-inflammation and immuno-regulation mechanism of taurochenodeoxycholic acid.
Bao L; Hao D; Wang X; He X; Mao W; Li P
BMC Pharmacol Toxicol; 2021 Apr; 22(1):23. PubMed ID: 33926569
[TBL] [Abstract][Full Text] [Related]
19. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
20. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Liu L; Lu W; Ma Z; Li Z
Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
